Finance

Lists
300142:SHE
Walvax Biotechnology Co Ltd
CNÂ¥12.98
-1.67%
(-0.22) 1D
Sep 4, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300142...
Open
CNÂ¥13.17
High
CNÂ¥13.31
Low
CNÂ¥12.95
Mkt. cap
20.76B
Avg. vol.
120.57M
Volume
74.54M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
111.58
52-wk high
CNÂ¥16.97
52-wk low
CNÂ¥10.88
EPS
CNÂ¥0.12
Shares outstanding
1.60B
No. of employees
2K
Open
CNÂ¥13.17
High
CNÂ¥13.31
Low
CNÂ¥12.95
Mkt. cap
20.76B
Avg. vol.
120.57M
Volume
74.54M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
111.58
52-wk high
CNÂ¥16.97
52-wk low
CNÂ¥10.88
EPS
CNÂ¥0.12
Shares outstanding
1.60B
No. of employees
2K
About Walvax Biotechnology Co Ltd
CEO-
Employees1.98K
FoundedJan 16, 2001
Headquarters-
SectorBiotechnology
Websitewalvax.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
564.60M
699.43M
443.85M
390.37M
Cost of goods sold
91.98M
145.27M
139.96M
131.33M
Cost of revenue
91.98M
145.27M
139.96M
131.33M
Research and development expenses
94.96M
76.11M
43.80M
64.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
286.83M
411.46M
214.69M
197.11M
Operating expense
404.88M
550.98M
154.28M
287.67M
Total operating expenses
496.86M
696.25M
294.24M
419.00M
Operating income
67.74M
3.18M
149.60M
-28.63M
Other non operating income
-2.25M
3.49M
-4.78M
4.41M
EBT including unusual items
124.24M
29.83M
128.94M
-59.73M
EBT excluding unusual items
83.99M
11.22M
143.66M
-35.62M
Income tax expense
13.63M
8.19M
14.52M
8.74M
Effective tax rate
10.97%
27.45%
11.26%
-14.64%
Other operating expenses
-1.00M
108.29K
-1.54M
32.11K
Net income
120.28M
14.30M
110.68M
-56.48M
Net profit margin
21.30%
2.04%
24.94%
-14.47%
Earnings per share
-
-
-
-
Interest and investment income
18.98M
8.09M
6.13M
4.89M
Interest expense
-
-906.16K
-7.06M
-9.61M
Net interest expenses
18.98M
7.18M
-931.24K
-4.72M
Depreciation and amortization charges
-
-
-
-
EBITDA
158.64M
98.50M
244.92M
55.24M
Gain or loss from assets sale
130.39K
-81.07K
-
-351.32K
AI content may include mistakes. Learn more
Google apps